These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7235061)

  • 41. Plasma levels of imipramine and adverse effects in children.
    Preskorn SH; Weller EB; Weller RA; Glotzbach E
    Am J Psychiatry; 1983 Oct; 140(10):1332-5. PubMed ID: 6624965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imipramine and clonazepam for panic disorder.
    Eppel AB
    Am J Psychiatry; 1989 Feb; 146(2):283-4. PubMed ID: 2912281
    [No Abstract]   [Full Text] [Related]  

  • 43. Duration of antidepressant trials: clinical and research implications.
    Donovan SJ; Quitkin FM; Stewart JW; Ocepek-Welikson K; Harrison W; McGrath PJ; Nunes EV; Wager S; Tricamo E
    J Clin Psychopharmacol; 1994 Feb; 14(1):64-6. PubMed ID: 8151005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Withdrawal symptoms after long-term treatment with flurazepam.
    Pearlman T
    Am J Psychiatry; 1984 Jan; 141(1):138-9. PubMed ID: 6691434
    [No Abstract]   [Full Text] [Related]  

  • 45. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
    Weissman MM; Prusoff B; Sholomskas AJ; Greenwald S
    J Clin Psychopharmacol; 1992 Jun; 12(3):175-82. PubMed ID: 1629383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder.
    Brown CS; Wells BG; Cold JA; Froemming JH; Self TH; Jabbour JT
    J Clin Psychopharmacol; 1990 Oct; 10(5):359-62. PubMed ID: 2258453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benzodiazepine tapering: a prospective study.
    Vikander B; Koechling UM; Borg S; Tönne U; Hiltunen AJ
    Nord J Psychiatry; 2010 Aug; 64(4):273-82. PubMed ID: 20629611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Withdrawal symptoms after abrupt termination of imipramine.
    Shatan C
    Can Psychiatr Assoc J; 1966; 11 Suppl():Suppl:150-8. PubMed ID: 5937819
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical management--imipramine/placebo administration manual. NIMH Treatment of Depression Collaborative Research Program.
    Fawcett J; Epstein P; Fiester SJ; Elkin I; Autry JH
    Psychopharmacol Bull; 1987; 23(2):309-24. PubMed ID: 3303100
    [No Abstract]   [Full Text] [Related]  

  • 50. Antidepressant withdrawal phenomena.
    Dilsaver SC; Greden JF
    Biol Psychiatry; 1984 Feb; 19(2):237-56. PubMed ID: 6324897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Withdrawal symptoms after interruption of alcohol dependence].
    Scholz H
    Fortschr Neurol Psychiatr; 1982 Sep; 50(9):279-96. PubMed ID: 7173802
    [No Abstract]   [Full Text] [Related]  

  • 52. Agoraphobia and imipramine withdrawal?
    Shrand H
    Pediatrics; 1982 Nov; 70(5):825. PubMed ID: 7133835
    [No Abstract]   [Full Text] [Related]  

  • 53. Diazepam withdrawal syndrome: its prolonged and changing nature.
    Mellor CS; Jain VK
    Can Med Assoc J; 1982 Dec; 127(11):1093-6. PubMed ID: 7139456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term imipramine withdrawal induces a depressive-like behaviour in the forced swimming test.
    D'Aquila PS; Panin F; Serra G
    Eur J Pharmacol; 2004 May; 492(1):61-3. PubMed ID: 15145707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mianserin and imipramine in the treatment of elderly depressed patients.
    Eklund K; Dunbar GC; Pinder RM; Steffensen K
    Acta Psychiatr Scand Suppl; 1985; 320():55-9. PubMed ID: 3863469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of the caffeine withdrawal symptom questionnaire: caffeine withdrawal symptoms cluster into 7 factors.
    Juliano LM; Huntley ED; Harrell PT; Westerman AT
    Drug Alcohol Depend; 2012 Aug; 124(3):229-34. PubMed ID: 22341956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Imipramine and neuro-psychiatry. Retrospective study of 557 out-patients treated in a neuro-psychiatric unit (author's transl)].
    Brion S; Boulenger JP
    Encephale; 1982; 8(1):49-63. PubMed ID: 7094871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The safety of a single daily dose schedule for imipramine.
    Saraf K; Klein DF
    Am J Psychiatry; 1971 Oct; 128(4):483-4. PubMed ID: 5098616
    [No Abstract]   [Full Text] [Related]  

  • 59. A controlled double blind comparative study of single dose administration of imipramine pamoate and divided dose of imipramine hydrochloride in depressive illness.
    Khorana AB
    Indian J Physiol Pharmacol; 1981; 25(4):331-8. PubMed ID: 7042559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imipramine withdrawal: an akathisia-like syndrome.
    Sathananthan GL; Gershon S
    Am J Psychiatry; 1973 Nov; 130(11):1286-7. PubMed ID: 4795181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.